The boom experienced by the weight loss drug market comes as little surprise when considering that almost a third of the ...

On the Board of Page, Dr. Gaugler joins Prof. Nicola Aceto, scientific founder, Prof. Christoph Rochlitz, MD, co-founder and CMO, as well as Daniele Scarinci, President and CEO and Ciro Spedaliere, ...

The firm will use to funds to validate its CD123-targeted CAR T-cell therapies in acute myeloid leukemia in clinical studies.

Bonus Aug 01, 2023 Aug 01, 2023 Jun 28, 2023 Bonus Ratio: 1 share(s) for every 1 shares held ...